Lidia Matesic completed a PhD in organic and medicinal chemistry at the University of Wollongong in 2011. She then commenced at ANSTO as a post-doctoral fellow and later on, as a radiochemist. During her research career she has focussed on the development of radiopharmaceuticals for cancer and neurological disorders. In 2012 she was awarded an Early Career Fellowship to work at Centre Cyceron (Caen, France) on the development of new PET imaging agents to diagnose stroke.
Lidia has expertise in radiolabelling optimisation, radiotracer production for preclinical studies, radiotracer characterisation, organic synthesis and student supervision. Currently, she is a Principal Radiochemist and the Radiopharmaceuticals Manager at ANSTO, leading a team of radiochemists researching the use of therapeutic radioisotopes to advance the development, manufacturing and translation of radiopharmaceuticals into preclinical and clinical studies.
New South Wales (NSW) Chief Scientist and Engineer, Prof Hugh Durrant-Whyte, has announced $1.6 million will be invested in National Imaging Facility (NIF) capabilities through the NSW NCRIS Support P
24 June 2024
The Commonwealth Government Department of Education has today announced National Imaging Facility (NIF) will receive $28m under the National Collaborative Research Infrastructure Strategy (NCRIS), to
19 October 2023